Hospitalist Doctors in Stamford, CT Accepting Medicare

7 Hospitalist doctors found. Showing 1 - 7

Dr. Zhaohui Wang, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Plz, Stamford, CT 06902 Phone: 032-767-2982    Fax: 203-276-4842

Kuntal Pujara, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Plz, Stamford, CT 06902 Phone: 203-276-7298

Rebecca Streeter, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1177 Summer St, Stamford, CT 06905 Phone: 203-653-4321    Fax: 203-353-1133

Christopher Robert Janowiecki, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Plz, Stamford, CT 06902 Phone: 203-276-7298    Fax: 203-276-4842

Dr. Rolando Ruiz Santos, M.D., M.H.A. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: One Hospital Plaza, Stamford, CT 06904 Phone: 203-276-7298    Fax: 203-276-4842

Fernando Barahona, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 38 Bungalow Park, Stamford, CT 06902 Phone: 203-424-7995

Lifan Hsu, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Plz, Stamford, CT 06902 Phone: 203-276-7298    Fax: 203-276-4842

News Archive

Purple Hoot supports Cancer Research UK

Visitors to www.purplehoot.com can choose from a wide range of cards, including traditional, contemporary, humorous and an exclusive Edward Monkton Xmas range, helping to raise funds to beat cancer at the same time. They also have the option to personalise cards by uploading their own images and add from a selection of seasonal clip art.

Wealthy patients beat cancer better than poorer counterparts: Survey

Cancer survival rates have improved across England, according to two new reports from the Office for National Statistics (ONS).But the reports also reveal that there are still gaps in survival, with patients from wealthy areas having a better chance of beating cancer than their poorer counterparts.

BrainStorm completes registered public offering of common stock

BrainStorm Cell Therapeutics Inc., an innovative developer of adult stem cell technologies and Central Nervous System (CNS) therapeutics, today announced that it completed a registered public offering of 19,818,972 shares of common stock at a price per share of $0.29 and warrants to purchase 14,864,229 shares of common stock at an exercise price of $0.29 per share, representing gross proceeds of $5,747,502.

TransPharma announces positive results of ViaDerm-hPTH Phase 1 trial for osteoporosis treatment

TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today successful results of a 4 week Phase 1 trial of its new self-applied ViaDerm-hPTH(1-34) for the treatment of osteoporosis.

LifeVantage pays Zrii $400,000 to settle litigation

LifeVantage Corporation, the maker of Protandim® and TrueScience(TM) Anti-Aging Cream, science-based solutions to oxidative stress, announced today that the Company has entered into a settlement agreement with, among other parties, Zrii, LLC.

Read more Medical News

› Verified 3 days ago